A Study to Assess the Safety, Tolerability and Efficacy of OP0201 as an Adjunct Treatment for Acute Otitis Media in Infants and Children Aged 6 to 24 Months

Condition:   Acute Otitis Media Interventions:   Drug: OP0201 20mg per day+Amoxicillin-clavulanate;   Drug: Placebo 0mg per day+Amoxicillin-clavulanate Sponsor:   Novus Therapeutics, Inc Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials